- Today's Hot Chat Topics
- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Gw Pharmaceuticals Share News (GWP)
Share News for Gw Pharmaceuticals (GWP)
| Share Price: 48.875 | Bid: 48.50 | Ask: 51.25 | Change: 0.00 (0.00%) |  | ||||||
| ||||||||||
UPDATE 1-GW cannabis drug wins green light in 6 new markets
LONDON, March 22 (Reuters) - GW Pharmaceuticals Plc's pioneering cannabis drug Sativex has been recommended for approval in the six other Europ[22 Mar '11]
BRIEF-GW Pharma's Sativex recommended in 6 more EU countries
LONDON, March 22 (Reuters) - GW Pharmaceuticals PLC: * Sativex mutual recognition procedure closes with recommendation for approval[22 Mar '11]
BRIEF-GW Pharma drug Sativex launched in Spain by Almirall
LONDON, March 14 (Reuters) - GW Pharmaceuticals PLC: * Sativex has been launched in Spain by gw's marketing partner almirall, s.a.[14 Mar '11]
BRIEF-GW gets Spanish financing approval for Sativex
LONDON, Feb 17 (Reuters) - GW Pharmaceuticals PLC: * Sativex granted reimbursement in Spain ((London Equities Newsroom; +44 20 7542[17 Feb '11]
UPDATE 2-Cannabis drug boosts profits at GW Pharma
By Brenda Goh LONDON, Nov 23 (Reuters) - GW Pharmaceuticals' profits rose sharply following the successful launch of its cannabis-derived[23 Nov '10]
UPDATE-2-Cannabis drug boosts profits at GW Pharma
By Brenda Goh LONDON, Nov 23 (Reuters) - GW Pharmaceuticals' profits rose sharply following the successful launch of its cannabis-derived[23 Nov '10]
REFILE-UPDATE-1-Cannabis drug boosts profits at GW Pharma
LONDON, Nov 23 (Reuters) - GW Pharmaceuticals' profits rose sharply following the successful launch of its cannabis-derived drug Sativex in Brit[23 Nov '10]
UPDATE-1-Cannabis drug boosts profits at GW Pharma
LONDON, Nov 22 (Reuters) - GW Pharmaceuticals' profits rose sharply following the successful launch of its cannabis-derived drug Sativex in Brit[23 Nov '10]
